The Mirae Asset Nifty 100 Low Volatility 30 ETF, managed by Mirae Asset Investment Managers, aims to replicate the Nifty 100 Low Volatility 30 Total Return Index through a low volatility investment strategy.

This open-ended ETF employs a tracking approach with a minimal tracking error of 0.05%, ensuring efficient replication of its benchmark, the Nifty 100 Low Volatility 30 (TRI).

The portfolio exhibits a concentrated holding structure, with top allocations in Hindustan Unilever (4.41%) and ITC (4.02%), while industry exposure is dominated by Pharmaceuticals & Biotechnology at 13.76%.

Over the past year, the fund has delivered impressive performance, with a change of 45.6%, although longer-term CAGR figures are not available, highlighting a focus on recent volatility management.

With an AUM of ₹46.7 Cr and a low expense ratio of 0.33%, this ETF provides accessible investment opportunities, managed by experienced professionals since March 2023 and 2025.